Answers are grounded in this paper and cite their sources.
The use of captopril in heart failure and hypertension is becoming increasingly accepted. Captopril has a sulphydryl group in its molecular structure. We wondered if this might confer free radical scavenging activity on the drug and have investigated this in an in vitro system. Results show that captopril is a free radical scavenger and we suggest that this action might be relevant in its use in heart failure and other vascular diseases.
No takes yet. Share an insight, caveat, or question.
Chopra et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: